Causes and frequency of blindness in patients with intraocular inflammatory disease

British Journal of Ophthalmology

Volumn 80, Issue 4, 1996, Pages 332-336

  Rothova, Aniki ^a,c,d   Suttorp van Schulten, Maria S A ^b,c   Frits Treffers, W ^a   Kijlstra, Aize ^c  

^a Academic Hospital Utrecht   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d Utrecht Universital Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLINDNESS; CONTROLLED STUDY; EYE INFLAMMATION; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA EDEMA; RISK FACTOR; SARCOIDOSIS; TOXOPLASMOSIS; UVEITIS; VISUAL IMPAIRMENT;

EID: 0029913597     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.4.332     Document Type: Article

References (41)

1. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990; 14: 303-8.
2. Forrester JV. Uveitis: pathogenesis. Lancet 1991; 338: 1498-501.
3. Vadot E, Barth E, Billet P. Epidemiology of uveitis - preliminary results of a prospective study in Savoy. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 13-6.
4. Ronday MJH, Stilma JS, Barbe RF, Kijlstra A, Rothova A. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol 1994; 78: 690-3.
5. Doesschate ten J. Causes of blindness in the Netherlands. Doc Ophthalmol 1982; 52: 279-85.
6. Research to Prevent Blindness. Annual report 1993. 598 Madison Avenue, New York, 1993: 4.
7. Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 234-6.
8. Nussenblatt RB, Palestine AG. Scleritis. In: Uveitis. Fundamentals and clinical practice. Chicago: Year Book Medical Publishers, 1989: 239-41.
9. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology 1994; 101: 389-96.
10. Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJJ, Linssen A, Alberts C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992; 76: 137-41.
11. Rothova A, van Knapen F, Baarsma GS, Kruit PJ, Loewer-Sieger DH, Kijlstra A. Serology in ocular toxoplasmosis. Br J Ophthalmol 1986; 70: 615-22.
12. Bennet PH, Burch TA. New York symposium on population studies in the rheumatic diseases. New diagnostic criteria. Bull Rheum Dis 1967; 17: 453-8.
13. Kraut JA, McCabe CP. The problem of low vision. Definition and common problems. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: W B Saunders, 1994; 5: 3664-6.
14. McGavin M. Reaching for high standards of eye care. Community Eye Health 1993; 6: 1-2.
15. Lightman S. Uveitis: management. Lancet 1991; 338: 1501-4.
16. Barton K, Hall AJH, Rosen PH, Cooling RJ, Lightman S. Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. Ocular Immunology and Inflammation 1994; 2: 207-16.
17. Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989; 72: 287-96.
18. Foster CS. Ocular manifestations of sarcoidosis preceding systemic manifestations. In: Grassi C, Rizatto G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Amsterdam: Exerpta Medica, 1988: 177-81.
19. Loewer-Sieger DH, Rothova A, Koppe JG, Kijlstra A. Congenital toxoplasmosis: a prospective study based on 1821 pregnant women. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 203-7.
20. Wilson CB, Remington JS, Stagno S, Reynold DW. Development of adverse sequelae in children born with subclinical toxoplasma infection. Pediatrics 1980; 66: 767-74.
21. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994; 18: 38-72.
22. McCabe R, Remington JS. Toxoplasmosis: the time has come. N Engl J Med 1988; 318: 313-5.
23. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 1994; 11: 57-62.
24. Rothova A, Veenendaal WG van, Linssen A, Glasius E, Kijlstra A, Jong PTVM de. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987; 103: 137-45.
25. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27 associated uveitis. Ophthalmology 1994; 101: 1267-74.
26. Boer de JH, Luyendijk L, Rothova A, Baarsma GS, Jong de PTVM, Bollemeijer JG, et al. Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol 1994; 117: 201-10.
27. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987; 94: 1242-8.
28. Weiss H, Annesley WH Jr, Shields JA, Tomer T, Christopherson K. The clinical course of serpiginous choroidopathy. Am J Ophthalmol 1979; 87: 133-42.
29. Laatikainen L, Erkkila H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol (Copenh) 1981; 59: 707-18.
30. Nussenblatt RB, Palestine AG. Birdshot retinochoroidopathy. In: Uveitis. Fundamentals and clinical practice. Chicago: Year Book Medical Publishers, 1989: 248-56.
31. Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol 1980; 89: 31-45.
32. Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol 1988; 72: 646-59.
33. Mamo JG. The rate of visual loss in Behçet's disease. Arch Ophthalmol 1970; 84: 451-2.
34. Cochereau-Massin I, Wechsler B, Le Hoang P, Le Thi Huong Du, Girard B, Rousselie F, et al. Prognostic oculaire de la maladie de Behçet. J Fr Ophtalmol 1992; 15: 343-47.
35. Towler HMA, Lightman S. Visual prognosis is Behçet's disease. Ocular Immunology and Inflammation 1993; 1: 249-54.
36. Hikichi T, Trempe CL. Role of the vitreous in the prog-nosis of peripheral uveitis. Am J Ophthalmol 1993; 116: 401-5.
37. Malinowski SM, Folk JC, Pulido JS. Pars planitis. Curr Opin Ophthalmol 1994; 5: 72-82.
38. Pruett RC, Brockhurst RJ, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol 1974; 77: 448-53.
39. Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc UK 1976; 96: 151-7.
40. Dick AD. The treatment of chronic uveitic macular oedema. Is immunosuppression enough? Br J Ophthalmol 1994; 78: 1-2.
41. Heiligenhaus A, Bornfeld N, Foerster MH, Wessing A. Long term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol 1994; 78: 549-54.